Amid U.K. cutbacks, AstraZeneca plows $520M into manufacturing and R&D in France

As Brexit draws near, British pharma major AstraZeneca is investing more in continental Europe, just as it cuts back in its home country.

AstraZeneca just unveiled a $520 million investment in France across the spectrum of manufacturing and R&D. The announcement came as French President Emmanuel Macron wooed business leaders during the “Choose France” summit amid ongoing turmoil over France's pension system.